We are live on !
Find out more
Ernexa Therapeutics
ERNA
ERNA
6 hedge funds and large institutions have $3.04M invested in Ernexa Therapeutics in 2015 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
0.03% more ownership
Funds ownership: 21.87% → 21.9% (+0.03%)
0% more funds holding
Funds holding: 6 → 6 (0)
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
ERNA Hedge Fund Activity: Q4 2015 in Review
6 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Ernexa Therapeutics (ERNA) for Q4 2015, worth a combined $3.04M — down 51% from $6.18M a quarter earlier.
Fund positioning in ERNA was balanced in Q4 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.
- 6 institutional investors held Ernexa Therapeutics (ERNA) as of Q4 2015, unchanged from Q3 2015.
- Funds reported $3.04M of Ernexa Therapeutics stock for Q4 2015, down 51% quarter-over-quarter.
- 0 funds opened new Ernexa Therapeutics positions in Q4 2015 and 0 closed out.
Based on aggregated 13F filings for Q4 2015.